Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06273995 · ClinicalTrials.gov registry record · NA

Telehealth Behavioral Activation for Teens

A NA study of Depression and Suicide and Self-harm, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT06273995: Recruiting NA study of Depression and Suicide and Self-harm, sponsored by Baylor College of Medicine.

NCT06273995 is a NA study of Depression and Suicide and Self-harm that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 250 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06273995, a NA study of Depression and Suicide and Self-harm, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g., socializing with family and friends, exercising, participating in a hobby) in order to improve depressive symptoms. Research has shown that behavioral activation is an effective intervention for depressed youth. Additionally, it has been shown as a promising intervention that can be conducted in a brief, virtual format and can be effectively implemented by both trained clinicians and trained, non-licensed interventionists. This project will provide Behavioral Activation for youth (12-17) experiencing depression or suicidal ideation who are currently enrolled in the Youth Depression Suicide Network study in Texas.

Primary Outcome

Depression; 4-point Likert scale (0= Not at all; 3= Nearly every day), Score range 0-27 (higher scores indicate greater depression severity)

Interventions

  • OTHER Behavioral Activation

Study Locations (1)

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-01
Est. Completion 2029-12-01
Phase NA
Baylor College of Medicine

616 total trials

What NCT06273995 shows while recruiting

NCT06273995 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (68% lower).

The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Behavioral Activation is the first listed.

NCT06273995 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06273995 about?

NCT06273995 is a clinical study titled "Telehealth Behavioral Activation for Teens". Behavioral activation is one such empirically supported intervention. Derived from cognitive-behavioral therapy, a well-established treatment for depression, behavioral activation uses psychoeducation and skill-building to increase an individual's engagement in valued and enjoyable activities (e.g.,...

What is the current status of trial NCT06273995?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-01. Estimated completion is 2029-12-01.

What conditions does trial NCT06273995 study?

This clinical trial studies the following conditions: Depression, Suicide and Self-harm, Depression in Adolescence, Depression Mild, Depression Moderate.

What interventions are being tested in trial NCT06273995?

The interventions under investigation include: Behavioral Activation (OTHER).

Who is sponsoring clinical trial NCT06273995?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06273995 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06273995's enrollment target sits among peer trials

250 173rd of 679 higher than 505 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06273995, the US trial registry maintained by the National Library of Medicine. NCT06273995 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.